Professor Karina Butler:

If the Deputy is referring to the clinical trials' data, basically, that is usually kept in any clinical trial by the investigators. In respect of drugs, when all that data is collated, it is then submitted to the regulatory agencies. It is not usually made public before it has gone through the regulatory submission. Some early parts of it, for example, the first phase trial data, was published. We will get that as it goes on. The bulk of the data which goes for registration, however, will go to the regulatory agencies before it becomes public. I hope that answers the question, and that was the question which the Deputy was asking.